Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs
01:20am, Friday, 28'th Feb 2025
SHANGHAI , Feb. 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializi
Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds
02:30pm, Thursday, 27'th Feb 2025
Moderna stock toppled Thursday on reports the Trump administration is considering pulling bird flu vaccine funding. The post Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Fl
Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award
11:08am, Thursday, 27'th Feb 2025
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
10:05am, Thursday, 27'th Feb 2025
Moderna (MRNA -6.67%) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. But you may be surprised to learn that now you can buy the stock around the
FDA Vaccine Panel Meeting To Discuss Flu Shots Reportedly Canceled
02:53am, Thursday, 27'th Feb 2025
A meeting of the Food and Drug Administration's vaccine advisory committee to discuss the next season's flu vaccine has reportedly been canceled, the second such disruption of a meeting involving vacc
Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports
07:38pm, Wednesday, 26'th Feb 2025
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
08:00am, Tuesday, 25'th Feb 2025
SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to
Moderna to Present at Upcoming Conferences in March 2025
07:00am, Tuesday, 25'th Feb 2025
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45th Annual Health Care C
CancerVax Announces Successful Tests of its Smart mRNA Technology
03:01am, Tuesday, 25'th Feb 2025
Recent in-vitro lab results confirm that the Company's proprietary Smart mRNA can be used as a potential on/off switch for selectively detecting cancer cells Recent in-vitro lab results confirm that t
Moderna (MRNA) International Revenue Performance Explored
10:15am, Monday, 24'th Feb 2025
Explore how Moderna's (MRNA) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus
09:30am, Monday, 24'th Feb 2025
Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China
06:05pm, Friday, 21'st Feb 2025
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.
Moderna and Other Vaccine Stocks Climb After Coronavirus News From China
05:30pm, Friday, 21'st Feb 2025
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.
3 Biotech/Healthcare Names Under $10 I Am Buying Now
04:21pm, Friday, 21'st Feb 2025
Today, I am highlighting three biotech/healthcare stocks that currently trade under $10 a share after some recent weakness. ! am slowly accumulating each of these names on these dips both straight equ
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
03:22am, Thursday, 20'th Feb 2025
In the dark days of the coronavirus pandemic, Moderna (MRNA 0.42%) was a ray of light in more ways than one. The healthcare company's innovative Spikevax was one of the go-to vaccines that sped to mar
